These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 9543128)

  • 1. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma.
    Spencer CA; Takeuchi M; Kazarosyan M; Wang CC; Guttler RB; Singer PA; Fatemi S; LoPresti JS; Nicoloff JT
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1121-7. PubMed ID: 9543128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC).
    Spencer CA
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3615-27. PubMed ID: 21917876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas.
    Spencer CA; Bergoglio LM; Kazarosyan M; Fatemi S; LoPresti JS
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5566-75. PubMed ID: 15985472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer.
    Spencer C; Petrovic I; Fatemi S
    J Clin Endocrinol Metab; 2011 May; 96(5):1283-91. PubMed ID: 21325460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research on comparison of thyroglobulin autoantibody interference in measurement of thyroglobulin between electrochemiluminescent assay and radioimmunoassay].
    Dai Q; Kuang A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Apr; 29(2):242-6. PubMed ID: 22616166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?
    Mariotti S; Barbesino G; Caturegli P; Marinó M; Manetti L; Pacini F; Centoni R; Pinchera A
    J Clin Endocrinol Metab; 1995 Feb; 80(2):468-72. PubMed ID: 7852506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of thyroglobulin antibody epitopes in differentiated thyroid cancer.
    Lupoli GA; Okosieme OE; Evans C; Clark PM; Pickett AJ; Premawardhana LD; Lupoli G; Lazarus JH
    J Clin Endocrinol Metab; 2015 Jan; 100(1):100-8. PubMed ID: 25322272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroglobulin measurement. Techniques, clinical benefits, and pitfalls.
    Spencer CA; Wang CC
    Endocrinol Metab Clin North Am; 1995 Dec; 24(4):841-63. PubMed ID: 8608781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discordance in thyroglobulin measurements by radioimmunoassay and immunometric assay: a useful means of identifying thyroglobulin assay interference.
    Crane MS; Strachan MW; Toft AD; Beckett GJ
    Ann Clin Biochem; 2013 Sep; 50(Pt 5):421-32. PubMed ID: 23847033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum thyroglobulin (Tg) monitoring of patients with differentiated thyroid cancer using sensitive (second-generation) immunometric assays can be disrupted by false-negative and false-positive serum thyroglobulin autoantibody misclassifications.
    Spencer C; Petrovic I; Fatemi S; LoPresti J
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4589-99. PubMed ID: 25226290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recovery test or immunoradiometric measurement of anti-thyroglobulin autoantibodies for interpretation of thyroglobulin determination in the follow-up of different thyroid carcinoma].
    Zöphel K; Wunderlich G; Liepach U; Koch R; Bredow J; Franke WG
    Nuklearmedizin; 2001 Oct; 40(5):155-63. PubMed ID: 11727628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The correlation between endogenous TgAb and experimental Tg values in patients with differentiated thyroid carcinomas].
    Tang GS; Xu J; Yu Y; Pan MZ; Wang JR; Yuan LP; Jiang T; Huang F; Jing CL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 42(6):856-60. PubMed ID: 22332559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroglobulin antibody (TgAb) methods - Strengths, pitfalls and clinical utility for monitoring TgAb-positive patients with differentiated thyroid cancer.
    Spencer C; Fatemi S
    Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):701-12. PubMed ID: 24094640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of Low Levels of Thyroglobulin Autoantibodies Associated with Undetectable Thyroglobulin After Thyroidectomy for Differentiated Thyroid Carcinoma.
    Latrofa F; Ricci D; Sisti E; Piaggi P; Nencetti C; Marinò M; Vitti P
    Thyroid; 2016 Jun; 26(6):798-806. PubMed ID: 27020734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of interference of thyroglobulin autoantibodies with assay of thyroglobulin using electrochemiluminescent assay].
    Dai Q; Kuang A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Aug; 28(4):780-3. PubMed ID: 21936380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of endogenous TgAb upon serum Tg measurement results and Tg positive rate in patients with differentiated thyroid carcinoma].
    Zhang W; Deng H; Pan M; Huang R; Tang G
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Aug; 30(4):803-7. PubMed ID: 24059060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].
    Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M
    Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroglobulin and thyroglobulin autoantibodies measurement using the automated KRYPTOR® platform in patients with differentiated thyroid carcinoma.
    Giovanella L; Toffalori E; Ceriani L; Caputo M; Verburg FA
    Horm Metab Res; 2011 Sep; 43(10):728-30. PubMed ID: 21932179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplexed immunoassay of thyroglobulin autoantibodies in patients with differentiated thyroid carcinoma.
    Giovanella L; Toffalori E; Tozzoli R; Caputo M; Ceriani L; Verburg FA
    Head Neck; 2012 Oct; 34(10):1369-71. PubMed ID: 22083639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the BRAHMS Kryptor(®) thyroglobulin minirecovery test in patients with differentiated thyroid carcinoma.
    Giovanella L; Imperiali M; Verburg FA; Ceriani L
    Clin Chem Lab Med; 2013 Feb; 51(2):449-53. PubMed ID: 23095203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.